Effects of ertugliflozin on kidney composite outcomes, renal function and albuminuria in patients with type 2 diabetes mellitus: an analysis from the randomised VERTIS CV trial Article

ESI Most Cited Paper Industry Collaboration International Collaboration

cited authors

  • Cherney, David Z. I.; Charbonnel, Bernard; Cosentino, Francesco; Dagogo-Jack, Samuel; McGuire, Darren K.; Pratley, Richard; Shih, Weichung J.; Frederich, Robert; Maldonado, Mario; Pong, Annpey; Cannon, Christopher P.; VERTIS CV Investigators

authors

Publication Date

  • March 4, 2021

webpage

published in

category

keywords

  • Cardiovascular disease
  • Diabetic nephropathies
  • Ertugliflozin
  • Type 2 diabetes mellitus

start page

  • 1256

end page

  • 1267

volume

  • 64

issue

  • 6